Improved CAR internalization and recycling through transmembrane domain optimization reduces CAR-T cytokine release and exhaustion
BackgroundAnti-CD19 chimeric antigen receptor T (CAR-T) cell therapy has proven effective for treating relapsed or refractory acute B cell leukemia. However, challenges such as cytokine release syndrome, T cell dysfunction, and exhaustion persist. Enha…